Recruiting for diversity in immunotherapy trials for breast and gynecologic cancers: moving beyond under-representation

Affiliations

¹ Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA aajazaeri@mdanderson.org.

Free article

Editorial

Travis T Sims et al. Int J Gynecol Cancer. 2021 Nov.

Free article

. 2021 Nov;31(11):1408-1409.

doi: 10.1136/ijgc-2021-003088. Epub 2021 Sep 22.

¹ Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA aajazaeri@mdanderson.org.

No abstract available

Keywords: cervical cancer; ovarian cancer; uterine cancer.

Conflict of interest statement

Competing interests: None declared.

Not immune to inequity: minority under-representation in immunotherapy trials for breast and gynecologic cancers.
Grette KV, White AL, Awad EK, Scalici JM, Young-Pierce J, Rocconi RP, Jones NL. Grette KV, et al. Int J Gynecol Cancer. 2021 Nov;31(11):1403-1407. doi: 10.1136/ijgc-2021-002557. Epub 2021 Jun 4. Int J Gynecol Cancer. 2021. PMID: 34088749